ChargePoint expands to target Central and North America
ChargePoint Technology has announced expansion plans to increase its offering across the US, Canada, Mexico and Puerto Rico.
Archives for July 24, 2017
Compounding quality concerns: Legislation could 'fundamentally undermine' patient protections
Citing safety concerns, drug industry stakeholders and public health organizations are urging lawmakers to uphold FDA oversight and enforcement of the 2013 Drug Quality and Security Act (DQSA).
Mitsubishi Tanabe to pay $1.1bn for Parkinson's drug formulator Neuroderm
Mitsubishi Tanabe Pharma has agreed to pay $1.1bn (€943m) to acquire Parkinson’s disease focused formulation and drug-device developer Neuroderm Ltd.
STA to supply intermediate for Tesaro 's $117k-a-year cancer drug Zejula
Tesaro Inc has hired STA Pharmaceutical Co. Ltd to supply intermediates for its recently approved, $117k-a-year, ovarian cancer drug Zejula (niraparib).
Outsourcing platform receives EU-US data security certification
Science Exchange has been certified under the EU-US Privacy Shield Framework after completing a seven-step process to demonstrate compliance with various data protection requirements.
Torbay Pharma opens plant with sterile injectables capacity in UK
Torbay Pharmaceuticals has opened a £26m injectable drug manufacturing facility in Paignton, UK.
Axim contracts Israel-based CRO for cannabidiol chewing gum clinical trials
An Israel-based contract research organization (CRO) is conducting a Ph II clinical trial for Axim’s cannabidiol (CBD) and Gabapentin chewing gum product.